B2B SaaS Provider
Reconomy vs StrongPoint
Structured technology and market comparison · 2026
Direct Feature Comparison
Reconomy · vs · StrongPointCircular economy software and services for waste, compliance and returns.
Retail technology vendor for store operations, fulfilment and retail media.
Analyze all overlapping signals and tech stacks for Reconomy and StrongPoint
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Reconomy and StrongPoint?
When comparing Reconomy and StrongPoint, both platforms operate within the Logistics & Retail Systems, B2B SaaS Provider, and Measurement & Analytics Platform ecosystem. Reconomy is positioned as Circular economy software and services for waste, compliance and returns, whereas StrongPoint focuses on Retail technology vendor for store operations, fulfilment and retail media. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Reconomy and StrongPoint?
When evaluating Reconomy and StrongPoint, enterprise buyers also consider other platforms in Logistics & Retail Systems, B2B SaaS Provider, and Measurement & Analytics Platform. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Reconomy and StrongPoint compare?
Reconomy is headquartered in GB (founded in 15 June 2017) with 1,001–5,000 employees. StrongPoint is based in NO (founded in 2002) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Reconomy vs StrongPoint
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Reconomy
Recent Signals
- ·Reconomy
Reconomy’s Chief Information Officer recognised as one of the UK’s top 100 CIOs
Reconomy’s Chief Information Officer recognised as one of the UK’s top 100 CIOs (25 September 2026). Also new: Deloitte Best Managed Company award for second consecutive year, call for government support on construction material reuse hubs, ESG Best Performer shortlist, National Sustainability Awards shortlist, Wolves matchday plastics community asset, EcoVend reverse vending at British Grand Prix, and colleague competing at Commonwealth Powerlifting Championships.
- ·Reconomy
Reconomy presented with Deloitte Best Managed Company award for second consecutive year
Reconomy presented with Deloitte Best Managed Company award for second consecutive year (16 September 2026). Also new: Reconomy calls on government to support UK network of construction material reuse hubs (1 September 2026), and shortlisted for ESG Best Performer of the Year at the Green Awards UK 2026 (10 August 2026).
StrongPoint
Recent Signals
- ·StrongPoint
Fast-Track Groceries: Morrisons Launches European Click & Collect Locker Technology in UK Supermarket First
Morrisons launches European Click & Collect locker technology in UK supermarket first, a new press release on StrongPoint's news page.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for StrongPoint
Sutro Biopharma, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing the financial impacts of its ongoing corporate transition and pipeline reorientation. Total revenue decreased 85% year-over-year to $9.8 million from $63.7 million in Q2 2025, primarily driven by the termination of the STRO-003 collaboration with Ipsen and the resulting derecognition of deferred revenue. The company posted a net loss of $38.5 million for the quarter, mitigated in part by lower operating expenses following a two-thirds workforce reduction in 2025 and an externalized CDMO manufacturing model. Liquidity was bolstered earlier in the year via an underwritten public offering generating $110.0 million in gross proceeds to advance clinical assets STRO-004 and STRO-006, alongside a $10.0 million clinical milestone achieved from partner Astellas.
- Q2 2026 revenue fell 85% year-over-year to $9.8 million (down from $63.7 million in Q2 2025) due to the termination of the Ipsen collaboration, resulting in a net loss of $38.5 million.
- The company secured $110.0 million in gross proceeds via an underwritten public offering in February 2026 and recognized a $10.0 million Phase 1 clinical milestone from partner Astellas.
- Operating structure reflects major 2025 cost-reduction initiatives, including a two-thirds workforce reduction and a transition to an outsourced CDMO manufacturing model.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Reconomy and StrongPoint share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks